Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cathepsin C | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | cathepsin C | 141 aa | 152 aa | 22.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0064 | 0.093 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0064 | 0.093 | 0.3712 |
Toxoplasma gondii | cathepsin CPC2 | 0.0087 | 0.1811 | 0.2497 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0 | 0.5 |
Onchocerca volvulus | 0.004 | 0 | 0.5 | |
Mycobacterium leprae | conserved hypothetical protein | 0.004 | 0 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.023 | 0.7253 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.004 | 0 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0143 | 0.3925 | 0.3925 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.093 | 0.093 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0064 | 0.093 | 0.1138 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.023 | 0.7253 | 1 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0067 | 0.1019 | 0.1019 |
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | 0.0087 | 0.1811 | 0.2497 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.023 | 0.7253 | 1 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0106 | 0.2506 | 1 |
Brugia malayi | jmjC domain containing protein | 0.0106 | 0.2506 | 0.2506 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0064 | 0.093 | 0.1283 |
Schistosoma mansoni | jumonji domain containing protein | 0.0084 | 0.1679 | 0.1679 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0589 | 0.0589 |
Schistosoma mansoni | glutaminase | 0.0302 | 1 | 1 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.023 | 0.7253 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.023 | 0.7253 | 1 |
Toxoplasma gondii | cathepsin CPC1 | 0.023 | 0.7253 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.093 | 0.093 |
Onchocerca volvulus | 0.004 | 0 | 0.5 | |
Onchocerca volvulus | 0.004 | 0 | 0.5 | |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0064 | 0.093 | 0.3712 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0045 | 0.0192 | 0.0768 |
Mycobacterium leprae | Probable lipase LipE | 0.004 | 0 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.093 | 0.093 |
Loa Loa (eye worm) | glutaminase | 0.0302 | 1 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.004 | 0 | 0.5 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0106 | 0.2506 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.0302 | 1 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0302 | 1 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0254 | 0.8174 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.093 | 0.093 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.023 | 0.7253 | 1 |
Echinococcus granulosus | jumonji domain containing protein | 0.0045 | 0.0192 | 0.0768 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.023 | 0.7253 | 0.7253 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.093 | 0.093 |
Mycobacterium ulcerans | glutaminase | 0.0302 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.